Effect of TNF inhibitors on the risk of cancer recurrence in patients with AS: a nested case-control study
TNFi exposure was not associated with an increased risk of cancer recurrence in patients with AS. Our findings suggest that TNFi may be used with caution in patients with AS and a history of cancer.
Authors
- Oh Chan Kwon (ORCID: https://orcid.org/0000-0001-7962-3697)
- Hye Sun Lee (ORCID: https://orcid.org/0000-0001-6328-6948)
- Soyoung Jeon (ORCID: https://orcid.org/0000-0002-9916-1917)
- Min‐Chan Park (ORCID: https://orcid.org/0000-0003-1189-7637)
Institutions
- Yonsei University (KR)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1093/rheumatology/keaf313
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52